Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Pneumococcal Vaccination in Older Adults
NCT00239694Phase 4Completed
- Sponsor
- National Institute on Aging
- Start
- Apr 2001
- Primary completion
- Aug 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 23-valent pneumococcal polysaccharide vaccine in Pneumococcal pneumonia (PP), sponsored by National Institute on Aging. Started Apr 2001; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT00239694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239694.